FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/105831 [Registered on: 10/03/2026] Trial Registered Prospectively
Last Modified On: 10/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A Comparative Study of the Efficacy of Oral Ivabradine and Oral Gabapentin in Attenuating Haemodynamic Response to Laryngoscopy and Endotracheal Intubation 
Scientific Title of Study   A Comparative Study Of The Efficacy Of Oral Ivabradine And Oral Gabapentin In Attenuating Haemodynamic Response To Laryngoscopy And Endotracheal Intubation 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Akhilesh Mukerji 
Designation  JUNIOR RESIDENT 
Affiliation  Dr D Y Patil Medical College Hospital and Research Centre 
Address  Department of Anaesthesia, 5th Floor, Hi-tech building, Dr. D.Y.Patil Medical College, Hospital and Research Centre, Sant Tukaram Nagar, Pimpri, Pune

Pune
MAHARASHTRA
411018
India 
Phone  7767981911  
Fax    
Email  akhileshmukerji@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bhavini Bhushan Shah 
Designation  Professor, Department of Anesthesiology 
Affiliation  Department of Anaesthesiology, Dr. D.Y.Patil Medical College, Hospital and Research Centre 
Address  Department of Anaesthesiology, Dr. D.Y.Patil Medical College, Hospital and Research Centre

Pune
MAHARASHTRA
411018
India 
Phone  9850829994  
Fax    
Email  bhavini.shah@dpu.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Bhavini Bhushan Shah 
Designation  Professor, Department of Anesthesiology 
Affiliation  Department of Anaesthesiology, Dr. D.Y.Patil Medical College, Hospital and Research Centre 
Address  Department of Anaesthesiology, Dr. D.Y.Patil Medical College, Hospital and Research Centre

Pune
MAHARASHTRA
411018
India 
Phone  9850829994  
Fax    
Email  bhavini.shah@dpu.edu.in  
 
Source of Monetary or Material Support  
Central pharmacy,5th floor, Hi-tech building, Dr. D.Y.Patil Medical college, Hospital and Research Centre, Sant Tukaram nagar, Pimpri, Pune, Maharashtra, India Pincode - 411018 
 
Primary Sponsor  
Name  AKHILESH MUKERJI 
Address  Department of Anaesthesia, 5th Floor, Hi-tech building, Dr. D.Y.Patil Medical College Hospital and Research Centre, Pimpri, Pune, Maharashtra, India, 411018 Medical College, Hospital and Research Centre, Sant Tukaram Nagar, Pimpri, Pune 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Akhilesh Mukerji  Dr. D.Y.Patil Medical College, Hospital and Research Centre  Sant Tukaram Nagar, Pimpri Colony, Pimpri-Chinchwad, Maharashtra 411018
Pune
MAHARASHTRA 
8800147678

akhileshmukerji@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Sub-Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I977||Intraoperative cardiac functionaldisturbances, (2) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  GABAPENTIN  TAB. GABAPENTIN 800MG 1 hour prior to induction of surgery 
Intervention  IVABRADINE  TAB. IVABRADINE 5MG 1 hour prior to induction of surgery 
Comparator Agent  PLACEBO  TAB. VITAMIN C GIVEN 1 hour prior to induction of surgery 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. ASA grade I or II fit patients.
2. Patients aged between 18 years and 60 years of age belonging to either sex
3. Patients undergoing surgeries under general anaesthesia requiring intubation.
4. Haemodynamically stable patients with all routine investigations within normal limits and
without any comorbidities.
5. Written informed consent from the concerned patient. 
 
ExclusionCriteria 
Details  1. Patients who have history of allergy to the drug being used for the study.
2. Patients who are not willing to participate in the study.
3. Patients will HR less than 60 and Heart Block conditions.
4. Patients on medications that affect the heart rate or blood pressure, pregnant patients.
5. Patients with ASA grade III and above physical status.
6. Patients who are aged less than 18 years and more than 60 years of age.
7. Patients who are posted for emergency procedures.
8. Patients who have psychiatric, neurological, cardiovascular disease, difficult airway or
impairment of hepatic or renal function. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the effects of oral Ivabradine and Gabapentin on haemodynamic response such
as Heart Rate (HR), Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Pressure (MAP) during laryngoscopy and intubation. 
Baseline (before administration of study drug),
preoperatively,
0 minute (intubation)
1 minute after intubation,
3rd minute after intubation,
5th minute after intubation,
8th minute after intubation,
10th minute after intubation,
30 minutes,
60 minutes
90 minutes
120 minutes
2 hours post operatively,
6 hours post operatively 
 
Secondary Outcome  
Outcome  TimePoints 
Determine which drug more effectively attenuates the haemodynamic response  Baseline (before administration of study drug),
preoperatively,
at induction,
at intubation,
1 minute after intubation,
3rd minute after intubation,
5th minute after intubation,
8th minute after intubation,
10th minute after intubation,
30 minutes,
60 minutes
90 minutes
120 minutes
2 hours post operatively,
6 hours post operatively 
To evaluate the incidence of adverse events & sedation related to the study drug.  Baseline (before administration of study drug),
preoperatively,
at induction,
at intubation,
1 minute after intubation,
3rd minute after intubation,
5th minute after intubation,
8th minute after intubation,
10th minute after intubation,
30 minutes,
60 minutes
90 minutes
120 minutes
2 hours post operatively,
6 hours post operatively 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   It is a prospective, randomized, comparative study to assess the attenuation of hemodynamic response to pre operative administration of Oral Ivabradine and Oral Gabapentin for patients undergoing surgeries under General Anaesthesia. Hemodynamic parameters such as SBP, DBP, MAP and HR will be recorded throughout the perioperative period and the efficacy of the mentioned drugs will be assessed.

Efficacy of the drugs will be compared and adverse effect profile will be assessed perioperatively. 
Close